English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
ACROMETA's Life Science Incubator (LSI) Signs Agreement with Ho Bee Land subsidiary to operate Co-Working Laboratory
Oct 06, 2023 17:30 HKT
The Story of Fosun and the Nobel Prize
Oct 05, 2023 17:11 HKT
ZeptoMetrix Awarded in Vitro Diagnostic Regulation (IVDR) Certification
Oct 03, 2023 21:00 HKT
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101
Oct 03, 2023 19:30 HKT
Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs
Sep 27, 2023 17:00 HKT
A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK

Sep 25, 2023 12:45 HKT
Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery
Sep 19, 2023 21:00 HKT
CGFNS Appoints New Chief Technology Officer to Lead its Digital Transformation
Sep 15, 2023 09:00 HKT
Vegan Cats Challenge Carnivorous Expectations
Sep 15, 2023 08:00 HKT
Focusing on the development of BsAbs in China, YZY Biopharma Announces Proposed Listing on the Main Board of SEHK
Sep 13, 2023 11:30 HKT
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
Sep 12, 2023 20:00 HKT
SinoMab's IND Application of SM17 has once again Received Approval from NAMP
Sep 12, 2023 09:48 HKT
Q&M Dental Group Sets the Gold Standard for Best Investor Relations at Singapore Corporate Awards
Sep 11, 2023 10:00 HKT
UroViu Corporation Appoints Ali Amiri as New President and Chief Operating Officer
Sep 06, 2023 21:00 HKT
Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals
Aug 29, 2023 13:00 HKT
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
Aug 28, 2023 19:30 HKT
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results
Aug 25, 2023 19:12 HKT
Hua Medicine Announces 2023 Interim Results
Aug 25, 2023 18:20 HKT
Universal Medical Announces 2023 Interim Results
Aug 24, 2023 20:30 HKT
Luzhu Biotechnology Announces 2023 Interim Results
Aug 23, 2023 11:20 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: